Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Thursday, July2
ORAL SESOS 150-1.0 15.0017.0

B46 HIV-Associated Neoplasia 0i
Chairs: Alexandra M. Levine, Andres Schmilovich
Venue: Session Hall VII
Time: 15.00-17.00
617 Effect of highly active antiretroviral treatment (HAART) 22275
in patients with AIDS-associated Kaposi's sarcoma (KS)
Sara Santambrogio*; A.L. Ridolfo; N. Tosca; M. Galli;
C. Parravicini; M. Corbellino, Italy
618 Topical 9-cis-Retinoic acid PanretinT gel as treatment 22277
of cutaneous AIDS-related Kaposi's sarcoma: Interim results
of an international, placebo-controlled trial (ALRT 1057-503)
Neil Bodsworth*; On Behalf of the International Panretin
KS Study Group Intern, Australia
619 North American phase 3 study (protocol L1057T-31) of 22283
PanretinT gel (LGD1057, ALRT1057) for cutaneous
AIDS-related Kaposi's sarcoma
Alvin Frie Dman-Kien*; M. Conant, USA
620 HHV-8, proliferation, apoptosis and ploidy in epidemic (AKS), 22282
endemic (EKS),and classical (CKS) Kaposi's sarcoma (KS)
Epahata Kaaya*; Peter Biberfeld; E. Castanous-Velez;
T. Heden; M. Stuzl; J.Z. Zou; J.N. Kitinya, Sweden
621 Association of vitamin A deficiency with cervical dysplasia 22301
in the Women's Interagency HIV Study (WIHS)
Audrey French*; M.H. Cohen; R. 0. Semba; J.K. Burke;
K.M. Weber; L.S. Massad, USA

C48 Bridging Session: Microbicides: 0 0
Towards a New Paradigm
Chairs: Lori Heise, Joseph Perriens
Venue: Session Hall V
Time: 15.00-17.00
630 Economic and marketing issues
Lieve Fransen
631 State-of-the-art: clinical research
Zeda Rosenberg
632 Pre-clinical overview: what possibilities exist?
Mark Wainberg
633 Case study for political advocacy: Zimbabwe
Priscilla Misihairabwi
634 Discussant: trials
Gita Ramjee
635 Discussant: consumer perspective
Kanokwan Gaye Tharawan
636 Discussant: government perspective
Debra Birnkrant

622 Case-control study of cervical cancer and HIV-infection
in Abidjan, Cbte d'lvoire
Georgette Adjorlolo-Johnson*; A. Anhoux; K. Toure-Coulibaly;
G. Laruche; G. Aissi; E. Unger; M. Honde; S. Vernon;
A.E. Greenburg; S.Z. Wiktor, COte d' lvoire
623 Incidence of squamous intraepithelial lesions (SIL) in

22305

22306

HIV-infected women
Marie-Christine Delmas*; A. Agarossi; C. Bergeron; F. Meier;
1. Paavonen; J.D. Poveda; J.A.R. Van Den Hoek, France
624 Comparison of the amount of HPV 16 DNA in cervicovaginal 22311
secretions of HIV-infected and uninfected women, using
quantitative competitive-polymerase chain reaction (QC-PCR)
Thomas Wright*;X. W. Sun; T.V. Ellerbrock; Chiasson, USA
B47 Grand Rounds: Clinical Case Studies
Chairs: David Chipanta, Michel P. Glauser
Venue: Arena
Time: 15.00-17.00
625 Case presentations
Amalio Telenti
626 Virologic failure
Joep Lange
627 Treatment complications
RobertSchooley
628 A case of HIV-infection in the developing world
Sin Yew Wong
629 Natural history of HIV-associated disease under HAART
Diane Havlir

NOTES

Pathway Symbols: 0 Gender 0 Policy

CONFERENCE WORKBOOK

183